相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immune-related adverse events in the gastrointestinal tract: diagnostic utility of upper gastrointestinal biopsies
M. Lisa Zhang et al.
HISTOPATHOLOGY (2020)
Immune-related adverse reactions in the hepatobiliary system: second-generation check-point inhibitors highlight diverse histological changes
Yoh Zen et al.
HISTOPATHOLOGY (2020)
Hepatotoxicity induced by immune checkpoint inhibitors: a comprehensive review including current and alternative management strategies
Joseph J. Jennings et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2019)
Immune checkpoint inhibitor-induced colitis: A comprehensive review
Aniruddh Som et al.
WORLD JOURNAL OF CLINICAL CASES (2019)
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
Filipe Martins et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Management of immune related adverse events induced by immune checkpoint inhibition
Andreas Teufel et al.
CANCER LETTERS (2019)
Evolution and recurrence of gastrointestinal immune-related adverse events induced by immune checkpoint inhibitors
Alice de Malet et al.
EUROPEAN JOURNAL OF CANCER (2019)
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Jonathan J. Havel et al.
NATURE REVIEWS CANCER (2019)
Immune checkpoint inhibitor colitis: the flip side of the wonder drugs
Naziheh Assarzadegan et al.
VIRCHOWS ARCHIV (2018)
Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors
Kristian M. Hargadon et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Gastrointestinal toxicity of immune checkpoint inhibitors: from mechanisms to management
Mark A. Samaan et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
Jun Gong et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Enterocolitis due to immune checkpoint inhibitors: a systematic review
Emilie Soularue et al.
GUT (2018)
Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors
Sabina Sandigursky et al.
CURRENT RHEUMATOLOGY REPORTS (2018)
Immune Checkpoint Inhibitor-Associated Colits and Hepatitis
Haritha G. Reddy et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2018)
Immune checkpoint inhibitors: recent progress and potential biomarkers
Pramod Darvin et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Severe Gastritis after Administration of Nivolumab and Ipilimumab
Yoshito Nishimura et al.
CASE REPORTS IN ONCOLOGY (2018)
PD-1 inhibitor gastroenterocolitis: case series and appraisal of 'immunomodulatory gastroenterocolitis'
Raul S. Gonzalez et al.
HISTOPATHOLOGY (2017)
Immunological Characteristics of Colitis Associated with Anti-CTLA-4 Antibody Therapy
Giorgos Bamias et al.
CANCER INVESTIGATION (2017)
Immune-related adverse events with immune checkpoint blockade: a comprehensive review
J. M. Michot et al.
EUROPEAN JOURNAL OF CANCER (2016)
Ipilimumab-Induced Enteritis without Colitis: A New Challenge
Marcus Messmer et al.
CASE REPORTS IN ONCOLOGY (2016)
Association Between Ipilimumab and Celiac Disease
Nicole M. Gentile et al.
MAYO CLINIC PROCEEDINGS (2013)
Prospective Evaluation of Acute Graft-Versus-Host Disease
Harry Aslanian et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
Endoscopic biopsy diagnosis of acute gastrointestinal graft-versus-host disease: Rectosigmoid biopsies are more sensitive than upper gastrointestinal biopsies
William A. Ross et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
α-CTLA-4 mAb-associated panenteritis -: A histologic and immunohistochemical analysis
Darryl A. Oble et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
分享论文
